← Back to headlines
Boston Scientific's $42M Stent Patent Verdict Reversed
Boston Scientific has successfully had a $42 million patent verdict related to stents reversed, marking a significant legal development for the company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
